Optionele productanalyse
Met uw toestemming gebruiken we privacyvriendelijke, beperkte analyses om te begrijpen welke onderzoeksroutes werken. We gebruiken geen advertentietrackers of sessieopnamen. U kunt deze keuze wijzigen in Voorkeuren. Lees het Privacybeleid.
DocuSign, Inc.'s published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $9.3B | |
|---|---|---|
| Revenue (ttm) | 3.4B | |
| Net income (ttm) | 329.9M | |
| EPS (ttm) | $1.64 | |
| Shares out | 186.9M | |
| P/E (trailing) | 50.8x | |
| P/E (forward) | 9.5x | |
| Volume | 1,164,209 | |
| Beta | 0.86 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | Trend |
|---|---|---|---|---|---|
| Period | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2026-01-31 | Trend |
| Revenue | $2.52B | $2.76B | $2.98B | $3.22B | +8.6% |
| Gross profit | $1.98B | $2.19B | $2.36B | $2.56B | +8.9% |
| Operating income | $-83.5M | $100.5M | $249.5M | $349.9M | — |
| Net income | $-97.5M | $74.0M | $1.07B | $309.1M | — |
| EPS (diluted) | $-0.49 | $0.36 | $5.08 | $1.48 | — |
| EBITDA | $2.8M | $195.6M | $357.3M | $466.0M | +452.5% |
| R&D | $480.6M | $539.5M | $588.5M | $665.0M | +11.4% |
| SG&A | $1.56B | $1.59B | $1.54B | $1.59B | +0.7% |
Recent company headlines from major financial publishers.
Successful expansion of Intelligent Agreement Management (IAM) accelerates revenue back to double-digits, while cost discipline drops the high incremental gross margins straight to the bottom line.
DocuSign is a mature software compounder generating exceptional free cash flow and maintaining dominant market share in e-signature. However, heavy stock-based compensation and decelerating top-line growth present valuation headwinds. The base case assumes steady, low-growth cash generation with gradual GAAP margin improvement.
| Ke ↓ / g → | 2.0% | 2.5% | 3.0% | 3.5% | 4.0% |
|---|---|---|---|---|---|
| 8.8% | $37.5 | $40.5 | $43.9 | $48.1 | $53.0 |
| 9.8% | $32.7 | $34.9 | $37.5 | $40.5 | $43.9 |
| 10.8% | $29.0 | $30.7 | $32.7 | $34.9 | $37.5 |
| 11.8% | $26.0 | $27.4 | $29.0 | $30.7 | $32.7 |
| 12.8% | $23.6 | $24.8 | $26.0 | $27.4 | $29.0 |
Upcoming earnings date and setup when available.
De rating die de gepubliceerde researcheditie van elke maand droeg. Een rating vergelijkt de koers op de analysedatum met de fair value; het is geen overzicht van of de inschatting juist bleek.
| Jaar | jan | feb | mrt | apr | mei | jun | jul | aug | sep | okt | nov | dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
